United States· US:71863-114_ce6d0fd4-bbe0-4a22-bfb5-33326b63a67f
Carglumic Acid
A carglumic acid product containing carglumic acid, registered in United States by Eton Pharmaceuticals, Inc.. The same ATC class is registered in 16 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Carglumic acid is registered in 16 of 19 countries.
Countries holding a registration under ATC A16AA05 (carglumic acid), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 9 of them publish a price we can compare per daily dose
Carglumic acid · ATC A16AA05
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of carglumic acid costs, country by country.
Normalised to the WHO defined daily dose (0.2 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Carglumic acid · price per daily dose (0.2 g)
USD · FX 28 Sept 2026
- IT Italy$92.77
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- CARGLUMIC ACID
- Manufacturer
- Eton Pharmaceuticals, Inc.
- Country
- United States (US)
- ATC code
- A16AA05
- ATC class
- Carglumic acid
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 2
- ndc1171863114601 BOTTLE in 1 CARTON (71863-114-60) / 60 TABLET, FOR SUSPENSION in 1 BOTTLE
- ndc1171863-114-60
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Carglumic acid in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainACIDO CARGLUMICO TILLOMED 200 MG COMPRIMIDOS DISPERSABLES EFGLaboratorios Tillomed Spain S.L.U
- ItalyACIDO CARGLUMICO WAYMADEWAYMADE B.V.
- FinlandCarbagluOrifarm Oy
- NetherlandsCarbaglu 200 mg, dispergeerbare tablettenOrphan Europe SARL
- FranceACIDE CARGLUMIQUE TILLOMED 200 mg, comprimé dispersible sécableTILLOMED PHARMA (ALLEMAGNE)
- NorwayCarbagluRecordati Rare Diseases
- United KingdomCarbaglu 200mg dispersible tabletsRecordati Rare Diseases UK Ltd
- PolandCarbagluRecordati Rare Diseases
Authorised across Europe · EMA
The same active substance is authorised in 17 EEA countries. Names it is sold under:
- Austria · Carglumsäure Waymade
- Czechia · Carglumic Acid
- Germany · Carglumsäure Waymade, Carglumsäure Zentiva
- Denmark · Cargluminsyre
- Spain · Ácido Carglúmico, Ácido Carglúmico Tillomed
- Finland · Karglumiinihappo Waymade
- France · Acide Carglumique Tillomed, Acide Carglumique Waymade
- United Kingdom (Northern Ireland) · Carglumic Acid Waymade
- Greece · Carglumic Acid, Carglumic Acid Tillomed
- Iceland · Carbaglu, Ucedane
- Italy · Acido Carglumico Waymade
- Liechtenstein · Carbaglu, Ucedane
- Netherlands · Carglumaatzuur Tillomed, Carglumaatzuur Waymade
- Norway · Carbaglu, Kargluminsyre Waymade
- Poland · Kwas Kargluminowy
- Portugal · Ácido Carglúmico, Ácido Carglúmico Waymade
- Sweden · Kargluminsyra Waymade
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/cdb2f8e1-062c-4655-8cc9-322199906d1f GET /v1/drugs/cdb2f8e1-062c-4655-8cc9-322199906d1f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "ORAL",
"source": "ndc",
"strength": "200",
"substance": "CARGLUMIC ACID",
"productndc": "71863-114",
"dosage_form": "TABLET, FOR SUSPENSION",
"dea_schedule": null,
"strength_unit": "mg/1",
"application_number": "ANDA213729",
"marketing_category": "ANDA"
}See everything about carglumic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.